Gaithersburg (United States)/Hyderabad, Sept 8 (ANI/Business Wire India): Ocimum Biosolutions today announced the issuance of U.S. Patent No. US 7,415,358 B2 entitled 'Molecular toxicology modeling'.
The patent describes elucidation of the global changes in gene expression and identification of toxicity markers in tissues or cells exposed to a known renal toxin. The genes can be used as toxicity markers in drug screening and toxicity assays.
The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes.
Anu Acharya, CEO, Ocimum Biosolutions, said, "We have consistently been in the forefront of Genomics Innovation over many years and this patent reiterates our strong commitment to continue as a leader in this space."
"Ocimum Biosolutions (Gene Logic) will continue to innovate through areas like Genotyping, Gene Expression, PCR and other data validation approaches to bring the latest and most promising technologies to our pharmaceutical and biotech clients who have chosen us as their preferred partner in their discovery pursuit for more than a decade," added Anu Acharya.